1eye wrote:The "MS" patient suffers from an awful disease that is indeed like an elephant -- the elephant in the room that nobody talks about. I want to talk about it. The elephant is division. From initial diagnosis the doctor has an important decision to make: one that will determine the patient's future indefinitely - what kind of "MS" do we have here?
I was asked at my first neurology appointment, when I asked for a treatment I had read of (I was referring to interferon) the guy said "What makes you think you are relapsing-remitting?"
I didn't know how important my answer was.
Why just 'MS'?
Could this elephant not be something else which does not need these divisons?
1eye wrote:Divide and conquer. PP, RR, SP, CP, etc. etc. Gets insurance companies, drug "vendors", and many doctors off the hook. Nobody has to do any more investigating or learning about anatomy, just leave everything to Big Pharma (the sister of Big Brother); a pen and a prescription pad is all you need. After a "case" becomes "SP", medicine stops working, so get them into the warehouse as soon as possible after that. Take away the driving license and the rest is easy, a waiting game, really.
It need not be so!
Big pharma brain washing is almost total. I cannot even put a different idea past many affected by the so called 'MS'
1eye wrote:An unfortunate coincidence that this usually happens about the same time people start to get impatient with having to come up with $30K-$50K a year for those "meds". For some reason, they don't like to keep injecting them into themselves, and swallowing them.
It is a gross underestimate:
$30bn: the combined revenue from the top 12 biological products in the United States in 2010
453%: expected increase in US sales of the above top 12 from 2010 to 2014. It will bring annual revenues to $166bn, comprising about 30% of the branded prescription drug market
$200 000: average cost of treating a patient for a year with one of the top nine biologicals in the US
$409 500: average cost per year for the average patient on the most expensive drug in the world, eculizumab, used to treat paroxysmal nocturnal haemoglobinuria
$2: average raw material cost per gram of product produced
1eye wrote:If doctors can just stonewall, stay the course, soon unruly troublemakers get passed on to warehousing, and they get all-new patients.
My contention is:
Should you have been there in the first place?
1eye wrote:Part of what keeps us "patients" in line is the tendency for saviours to appear who have a single answer for everyone's problems. The thing that all of the saviours, allopaths and otherwise, is each other: there will never, ever, be agreement among them. They are all in agreement on that. Nor will there ever be any solidarity among the afflicted. They have too many cognitive problems.
An interesting post on the MS Society forum went like this:
"There are three big problems for the constituency that believe to their very core in the scientific method:
A. You don't know what causes MS
B. You haven't found any methods for rolling it back
C. You haven't found a cure."
And in a later post he said:
"I believe the scientific method will 'one day' make a breakthrough.
Until then, I (for one) will be open for listening to maverick outsiders, garden shed boffins and spurious snake oil salesmen.
I mean, why wouldn't you?
Being open to stunning developments is one of life's great joys."